{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:52:31Z","timestamp":1790315551532,"version":"4.1.0"},"reference-count":18,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1191923"],"award-info":[{"award-number":["OPP1191923"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2023,3,24]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The WHO recommends use of the RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      (RTS,S) malaria vaccine for young children living in areas of moderate to high\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Immunisation (EPI) and (3) mixed delivery (mass campaign and routine EPI)), from the government\u2019s perspective. Resource use data are informed by previous new vaccine introductions, supplemented with primary data from a sample of health facilities and administrative units.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>At an assumed vaccine price of US $5 per dose, the economic cost per dose administered ranges between $7.73 and $8.68 (mass campaign), $7.04 and $7.38 (routine EPI) and $7.26 and $7.93 (mixed delivery). Excluding commodities, the cost ranges between $1.17 and $2.12 (mass campaign), $0.48 and $0.82 (routine EPI) and $0.70 and $1.37 (mixed delivery). The financial non-commodity cost per dose administered ranges between $0.99 and $1.99 (mass campaign), $0.39 and $0.76 (routine EPI) and $0.58 and $1.28 (mixed delivery). Excluding commodity costs, service delivery is the main cost driver under the mass campaign scenario, accounting for 36% to 55% of the financial cost. Service delivery accounts for 2%\u20138% and 12%\u201323% of the total financial cost under routine EPI and mixed delivery scenarios, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vaccine delivery using the mass campaign approach is most costly followed by mixed delivery and routine EPI delivery approaches, in both countries. Our cost estimates provide useful insights for decisions regarding delivery approaches, as countries plan the malaria vaccine rollout.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2022-011316","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:40:13Z","timestamp":1681728013000},"page":"e011316","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Cost of introducing and delivering malaria vaccine (RTS,S\/AS01\n                    <sub>E<\/sub>\n                    ) in areas of seasonal malaria transmission, Mali and Burkina Faso"],"prefix":"10.1136","volume":"8","author":[{"given":"Halimatou","family":"Diawara","sequence":"first","affiliation":[{"name":"Malaria Research and Training Centre, University of Science Techniques and Technologies of Bamako, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadima Yaya","family":"Bocoum","sequence":"additional","affiliation":[{"name":"Chercheur en sciences sociales, Institut de Recherche en Sciences de la Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[{"name":"Malaria Research and Training Centre, University of Science Techniques and Technologies of Bamako, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Levin","sequence":"additional","affiliation":[{"name":"Levin & Morgan LLC, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2615-7420","authenticated-orcid":false,"given":"Cynthia","family":"Lee","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata","family":"Koita","sequence":"additional","affiliation":[{"name":"Malaria Research and Training Centre, University of Science Techniques and Technologies of Bamako, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Bosco","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Sciences do la Sante, Bobo-Dioulasso, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemonde","family":"Guissou","sequence":"additional","affiliation":[{"name":"Chercheur en sciences sociales, Institut de Recherche en Sciences de la Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seydou","family":"Yabr\u00e9","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Thomas Sankara, Saaba, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-2788","authenticated-orcid":false,"given":"Seydou","family":"Traor\u00e9","sequence":"additional","affiliation":[{"name":"Malaria Research and Training Centre, University of Science Techniques and Technologies of Bamako, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winthrop","family":"Morgan","sequence":"additional","affiliation":[{"name":"Levin & Morgan LLC, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-6070","authenticated-orcid":false,"given":"Ranju","family":"Baral","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2025072915013487000_8.4.e011316.1","unstructured":"World Health Organization (WHO) . World malaria report 2021. 2021. Available: https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021"},{"key":"2025072915013487000_8.4.e011316.2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N Engl J Med"},{"key":"2025072915013487000_8.4.e011316.3","unstructured":"World Health Organization . Malaria vaccine: WHO position paper \u2013 march 2022. weekly epidemiological record. 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/who-wer9709-61%E2%80%9380"},{"key":"2025072915013487000_8.4.e011316.4","unstructured":"World Health Organization (WHO) . Full evidence report on the RTS,S\/AS01 malaria vaccine. 2021. Available: https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/mvip\/full-evidence-report-on-the-rtss-as01-malaria-vaccine-for-sage-mpag-%28sept2021%29.pdf"},{"key":"2025072915013487000_8.4.e011316.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244995","article-title":"Costs of continuing RTS,S\/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries","volume":"16","author":"Baral","year":"2021","journal-title":"PLoS ONE"},{"key":"2025072915013487000_8.4.e011316.6","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1016\/j.vaccine.2015.10.079","article-title":"Costing RTS,S introduction in burkina faso, ghana, kenya, senegal, tanzania, and uganda: A generalizable approach drawing on publicly available data","volume":"33","author":"Galactionova","year":"2015","journal-title":"Vaccine"},{"key":"2025072915013487000_8.4.e011316.7","doi-asserted-by":"crossref","DOI":"10.1177\/2381468319896280","article-title":"The costs of implementing vaccination with the RTS,S malaria vaccine in five sub-saharan african countries","volume":"4","author":"Sicuri","year":"2019","journal-title":"MDM Policy Pract"},{"key":"2025072915013487000_8.4.e011316.8","unstructured":"Grant J . Acceptability and feasibility of seasonal RTS,S\/AS01E vaccination, and recommendations for its implementation [study protocol]. London London School of Hygiene & Tropical Medicine; 2020."},{"key":"2025072915013487000_8.4.e011316.9","unstructured":"Brenzel L . Common approach for the costing and financing of routine immunization and new vaccines (EPIC). Working paper: Immunization Economics; 2014. Available: https:\/\/static1.squarespace.com\/static\/556deb8ee4b08a534b8360e7\/t\/62bb16c83c114a5786d72900\/1656428265663\/FINAL+EPIC+Common+Approach+Working+Paper+0814.pdf"},{"key":"2025072915013487000_8.4.e011316.10","unstructured":"World Health Organization (WHO) . Guidelines for estimating costs of introducing new vaccines into the national immunization system. 2022. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/67342"},{"key":"2025072915013487000_8.4.e011316.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02278-4","article-title":"WHO-led consensus statement on vaccine delivery costing: process, methods, and findings","volume":"20","author":"Levin","year":"2022","journal-title":"BMC Med"},{"key":"2025072915013487000_8.4.e011316.12","unstructured":"Thinkwell.global . Findings from immunization campaign costing studies: policy and program implications [policy brief]. 2022. Available: https:\/\/thinkwell.global\/wp-content\/uploads\/2022\/03\/Campaign-costing-policy-brief_final.pdf"},{"key":"2025072915013487000_8.4.e011316.13","unstructured":"Minist\u00e8re de la Sant\u00e9 . Minist\u00e8re de la sant\u00e9 et de l\u2019Hygi\u00e8ne publique website. n.d. Available: https:\/\/www.sante.gov.bf\/ressources\/documents?tx_news_pi1=17&cHash=568c1b79c198cf2051708cc5189eb751"},{"key":"2025072915013487000_8.4.e011316.14","unstructured":"PopulationData.net website. n.d. Available: https:\/\/www.populationdata.net\/pays\/mali\/"},{"key":"2025072915013487000_8.4.e011316.15","unstructured":"Republique du Mali . Annuaire 2020: systeme nationale d\u2019Information sanitaire et social (SNISS). 2021. Available: https:\/\/files.aho.afro.who.int\/afahobckpcontainer\/production\/files\/Annuaire_SNISS_2020.pdf"},{"key":"2025072915013487000_8.4.e011316.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00725-4"},{"key":"2025072915013487000_8.4.e011316.17","unstructured":"Ministere de la Sante, Burkina Faso . Normes en personnels des formations sanitaires publiques. 2016. Available: https:\/\/europa.eu\/capacity4dev\/file\/78752\/download?token=CIZSjVqu"},{"key":"2025072915013487000_8.4.e011316.18","unstructured":"The World Bank . Official exchange rate page. Available: https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF [Accessed 15 Oct 2022]."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2022-011316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:01:44Z","timestamp":1753826504000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2022-011316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,17]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/bmjgh-2022-011316"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2022-011316","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}